CONTINUING MEDICAL EDUCATION

---

DEPARTMENT OF INTERNAL MEDICINE

MEDICAL GRAND ROUNDS

Clinical Vignettes

“Takotsubo Cardiomyopathy - Psychosomatic Considerations”

 George Costin M.D., Vaskar Mukerji M.D., David Resch M.D.

Learning Objectives:  At the conclusion of this activity, attendees will be able to:
  1.     recognize the clinical presentation and prognosis of Takotsubo cardiomyopathy (TC).
 2.     discuss proposed pathophysiologic mechanisms, diagnostic criteria and treatment of TC.
3.     promote further studies of the emotional triggers associated with TC and to propose an approach to the condition from a psychosomatic perspective.

 

“Mucormycosis”

    1.              Demonstrate the clinical presentation and management of mucormycosis.

8:00 a.m.Wedeberg Conference Center Memorial Medical Center – Room E-72

Sponsorship
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education through SIU School of Medicine.  The SIU School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit
The SIU School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Unapproved Uses of Drugs/Devices
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. (Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.) The ACCME requires that faculty disclose when he/she intend to discuss off-label uses in a presentation.

Faculty Disclosures:  All faculty participating in CME activities are expected to disclose to the audience any real or apparent commercial financial affiliations related to the content of their presentations/materials.  In addition, faculty are expected to disclose any intent to discuss the off-label uses of any drugs or devices. 

Drs.  Costin, Resch, Mukerji, Elmahi and Koirala state they have nothing to disclose.